Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc.verified

TECX

Price:

$30.28

Market Cap:

$571.36M

Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator ...[Read more]

Industry

Biotechnology

IPO Date

2018-06-21

Stock Exchange

NASDAQ

Ticker

TECX

The Enterprise Value as of June 2026 (TTM) for Tectonic Therapeutic, Inc. (TECX) is 339.10M

According to Tectonic Therapeutic, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 339.10M. This represents a change of 130.01% compared to the average of 147.43M of the last 4 quarters.

Tectonic Therapeutic, Inc. (TECX) Historical Enterprise Value (quarterly & annually)

How has TECX Enterprise Value performed in the past?

The mean historical Enterprise Value of Tectonic Therapeutic, Inc. over the last ten years is 321.03M. The current 339.10M Enterprise Value has changed 10.46% with respect to the historical average. Over the past ten years (40 quarters), TECX's Enterprise Value was at its highest in in the March 2018 quarter at 688.90M. The Enterprise Value was at its lowest in in the March 2022 quarter at -88965615.84.

Quarterly (TTM)
Annual

Average

321.03M

Median

257.24M

Minimum

880.68K

Maximum

741.47M

Tectonic Therapeutic, Inc. (TECX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tectonic Therapeutic, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.97%

Maximum Annual Enterprise Value = 741.47M

Minimum Annual Increase = -99.36%

Minimum Annual Enterprise Value = 880.68K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025129.69M-76.16%
2024543.93M1.42%
202335.86M3.97%
2022880.68K-99.36%
2021137.98M-43.69%
2020245.03M-32.90%
2019365.17M35.52%
2018269.46M-63.63%
2017740.87M-0.08%

Tectonic Therapeutic, Inc. (TECX) Average Enterprise Value

How has TECX Enterprise Value performed in the past?

The current Enterprise Value of Tectonic Therapeutic, Inc. (TECX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

236.49M

5-year avg

169.67M

10-year avg

321.03M

Tectonic Therapeutic, Inc. (TECX) Enterprise Value vs. Peers

How is TECX’s Enterprise Value compared to its peers?

Tectonic Therapeutic, Inc.’s Enterprise Value is less than Alto Neuroscience, Inc. (495.40M), greater than Larimar Therapeutics, Inc. (122.82M), greater than Cellectis S.A. (305.53M), greater than Lyell Immunopharma, Inc. (263.73M), greater than Amarin Corporation plc (189.73M), greater than AC Immune S.A. (171.77M), less than DBV Technologies S.A. (368.39M), less than Alpha Tau Medical Ltd. (895.61M), greater than Silence Therapeutics plc (310.47M), greater than Aldeyra Therapeutics, Inc. (56.68M),

Build a custom stock screener for Tectonic Therapeutic, Inc. (TECX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tectonic Therapeutic, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tectonic Therapeutic, Inc. (TECX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tectonic Therapeutic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Tectonic Therapeutic, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Tectonic Therapeutic, Inc. (TECX)?

What is the 3-year average Enterprise Value for Tectonic Therapeutic, Inc. (TECX)?

What is the 5-year average Enterprise Value for Tectonic Therapeutic, Inc. (TECX)?

How does the current Enterprise Value for Tectonic Therapeutic, Inc. (TECX) compare to its historical average?